{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:28:17Z","timestamp":1790263697605,"version":"4.1.0"},"reference-count":28,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1604,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1111\/j.1528-1167.2011.03056.x","type":"journal-article","created":{"date-parts":[[2011,4,11]],"date-time":"2011-04-11T17:43:39Z","timestamp":1302543819000},"page":"1292-1296","source":"Crossref","is-referenced-by-count":154,"title":["Second-line status epilepticus treatment: Comparison of phenytoin, valproate, and levetiracetam"],"prefix":"10.1111","volume":"52","author":[{"given":"Vincent","family":"Alvarez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marie","family":"Januel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Burnand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea O.","family":"Rossetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,4,11]]},"reference":[{"key":"10.1111\/j.1528-1167.2011.03056.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.seizure.2007.04.012","article-title":"Randomized study of intravenous valproate and phenytoin in status epilepticus","volume":"16","author":"Agarwal","year":"2007","journal-title":"Seizure"},{"key":"10.1111\/j.1528-1167.2011.03056.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJMoa002141","article-title":"A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus","volume":"345","author":"Alldredge","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1528-1167.2011.03056.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1007\/s00415-009-5166-7","article-title":"Intravenous levetiracetam as treatment for status epilepticus","volume":"256","author":"Berning","year":"2009","journal-title":"J Neurol"},{"key":"10.1111\/j.1528-1167.2011.03056.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1212\/WNL.55.5.693","article-title":"Incidence of status epilepticus in French-speaking Switzerland: EPISTAR","volume":"55","author":"Coeytaux","year":"2000","journal-title":"Neurology"},{"key":"10.1111\/j.1528-1167.2011.03056.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/j.1528-1157.1993.tb00433.x","article-title":"Guidelines for epidemiologic studies on epilepsy","volume":"34","author":"Commission on Epidemiology and Prognosis, International League against Epilepsy","year":"1993","journal-title":"Epilepsia"},{"key":"10.1111\/j.1528-1167.2011.03056.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1385\/NCC:3:2:161","article-title":"Phenytoin poisoning","volume":"3","author":"Craig","year":"2005","journal-title":"Neurocrit Care"},{"key":"10.1111\/j.1528-1167.2011.03056.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1600-0404.2008.01097.x","article-title":"Treatment of status epilepticus and acute repetitive seizures with i.v. valproic acid vs phenytoin","volume":"118","author":"Gilad","year":"2008","journal-title":"Acta Neurol Scand"},{"key":"10.1111\/j.1528-1167.2011.03056.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1136\/jech.55.7.508","article-title":"A heuristic approach to the formulas for population attributable fraction","volume":"55","author":"Hanley","year":"2001","journal-title":"J Epidemiol Community Health"},{"key":"10.1111\/j.1528-1167.2011.03056.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1600-0404.2010.01423.x","article-title":"Intravenous lacosamide for treatment of status epilepticus","volume":"123","author":"Kellinghaus","year":"2011","journal-title":"Acta Neurol Scand"},{"key":"10.1111\/j.1528-1167.2011.03056.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1046\/j.1528-1157.2001.01101.x","article-title":"Incidence of status epilepticus in adults in Germany: a prospective, population-based study","volume":"42","author":"Knake","year":"2001","journal-title":"Epilepsia"},{"key":"10.1111\/j.1528-1167.2011.03056.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1136\/jnnp.2007.130260","article-title":"Intravenous levetiracetam in the treatment of benzodiazepine refractory status epilepticus","volume":"79","author":"Knake","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1111\/j.1528-1167.2011.03056.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1001\/jama.249.11.1452","article-title":"Double-blind study of lorazepam and diazepam in status epilepticus","volume":"249","author":"Leppik","year":"1983","journal-title":"JAMA"},{"key":"10.1111\/j.1528-1167.2011.03056.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1111\/j.1528-1157.1997.tb00073.x","article-title":"Short-term mortality after a first episode of status epilepticus","volume":"38","author":"Logroscino","year":"1997","journal-title":"Epilepsia"},{"key":"10.1111\/j.1528-1167.2011.03056.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1056\/NEJM199804023381407","article-title":"Status epilepticus","volume":"338","author":"Lowenstein","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1528-1167.2011.03056.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1468-1331.2009.02917.x","article-title":"EFNS guideline on the management of status epilepticus in adults","volume":"17","author":"Meierkord","year":"2010","journal-title":"Eur J Neurol"},{"key":"10.1111\/j.1528-1167.2011.03056.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/oxfordjournals.aje.a121617","article-title":"Proportion of disease caused or prevented by a given exposure, trait or intervention","volume":"99","author":"Miettinen","year":"1974","journal-title":"Am J Epidemiol"},{"key":"10.1111\/j.1528-1167.2011.03056.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1212\/01.wnl.0000224880.35053.26","article-title":"Sodium valproate vs phenytoin in status epilepticus: a pilot study","volume":"67","author":"Misra","year":"2006","journal-title":"Neurology."},{"key":"10.1111\/j.1528-1167.2011.03056.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1528-1167.2009.02323.x","article-title":"Refractory status epilepticus: a prospective observational study","volume":"51","author":"Novy","year":"2010","journal-title":"Epilepsia"},{"key":"10.1111\/j.1528-1167.2011.03056.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/BF00341575","article-title":"Results of parenteral diphenylhydantoin therapy of status epilepticus from the years 1959-1965","volume":"212","author":"Pilz","year":"1969","journal-title":"Arch Psychiatr Nervenkr"},{"key":"10.1111\/j.1528-1167.2011.03056.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.yebeh.2006.01.006","article-title":"Determinants of success in the use of oral levetiracetam in status epilepticus","volume":"8","author":"Rossetti","year":"2006","journal-title":"Epilepsy Behav"},{"key":"10.1111\/j.1528-1167.2011.03056.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1136\/jnnp.2005.080887","article-title":"Prognosis of status epilepticus: role of aetiology, age, and consciousness impairment at presentation","volume":"77","author":"Rossetti","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1111\/j.1528-1167.2011.03056.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1007\/s00415-008-0989-1","article-title":"Status Epilepticus Severity Score (STESS): a tool to orient early treatment strategy","volume":"255","author":"Rossetti","year":"2008","journal-title":"J Neurol"},{"key":"10.1111\/j.1528-1167.2011.03056.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1212\/WNL.55.5.722","article-title":"Intravenous valproate is well tolerated in unstable patients with status epilepticus","volume":"55","author":"Sinha","year":"2000","journal-title":"Neurology"},{"key":"10.1111\/j.1528-1167.2011.03056.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1528-1157.1994.tb02908.x","article-title":"Determinants of mortality in status epilepticus","volume":"35","author":"Towne","year":"1994","journal-title":"Epilepsia"},{"key":"10.1111\/j.1528-1167.2011.03056.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1056\/NEJM199809173391202","article-title":"A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group","volume":"339","author":"Treiman","year":"1998","journal-title":"N Engl J Med"},{"issue":"suppl 12","key":"10.1111\/j.1528-1167.2011.03056.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1528-1167.2009.02368.x","article-title":"What is the relative value of the standard anticonvulsants: phenytoin and fosphenytoin, phenobarbital, valproate, and levetiracetam?","volume":"50","author":"Trinka","year":"2009","journal-title":"Epilepsia"},{"key":"10.1111\/j.1528-1167.2011.03056.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1046\/j.1528-1157.2003.63702.x","article-title":"Incidence and short-term prognosis of status epilepticus in adults in Bologna, Italy","volume":"44","author":"Vignatelli","year":"2003","journal-title":"Epilepsia"},{"key":"10.1111\/j.1528-1167.2011.03056.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1212\/WNL.18.6.513","article-title":"Intravenous diphenylhydantoin in treatment of acute repetitive seizures","volume":"18","author":"Wallis","year":"1968","journal-title":"Neurology"}],"container-title":["Epilepsia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1528-1167.2011.03056.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1528-1167.2011.03056.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T23:39:53Z","timestamp":1625528393000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1528-1167.2011.03056.x"}},"subtitle":["Second-Line Status Epilepticus Treatment"],"short-title":[],"issued":{"date-parts":[[2011,4,11]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,7]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1528-1167.2011.03056.x","relation":{},"ISSN":["0013-9580"],"issn-type":[{"value":"0013-9580","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4,11]]}}}